Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Description of Routine Treatment Pathways in a Cohort of Patients With Major Depression and "Active Suicidal Ideation With Intent" in Italy: the Arianna Observational Study.

NCT04463108 is registered in ClinicalTrials.gov with Janssen-Cilag S.p.A. as lead sponsor.

NCT NCT04463108
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04463108 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Description of Routine Treatment Pathways in a Cohort of Patients With Major Depression and "Active Suicidal Ideation With Intent" in Italy: the Arianna Observational Study.
Lead sponsor
Janssen-Cilag S.p.A.
Phase
Observational
Overall status
Completed
Start date
June 23, 2020
Completion date
November 8, 2021
Enrollment
136 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

depressive disorder, major, suicidal ideation